Tumor cell targeting by iron oxide nanoparticles is dominated by different factors in vitro versus in vivo.

by Christian NDong, Jennifer A Tate, Warren C Kett, Jaya Batra, Eugene Demidenko, Lionel D Lewis, P Jack Hoopes, Tillman U Gerngross, Karl E Griswold
Published 2015-01-01